Skip to content
GLP-1 Desk
Menu
Dispatch #388

MANÜ Telehealth

MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections.

Visit MANÜ TelehealthAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$120/mo (compounded)
Tirzepatide
$150/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh MANÜ Telehealth against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: MANÜ Telehealth vs CoreAge Rx. Because MANÜ Telehealth dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency38/100
State access24/100
Molecule range66/100
Onboarding speed70/100
Support responsiveness77/100
Licensing & trust74/100

What the Desk likes

  • Compounded GLP-1s advertised from about $4-$5/day
  • 100% online with free discreet shipping and no insurance needed
  • Compounds exclusively from US 503A pharmacies
  • Add-on options like MIC Ultraburn and NAD+

Where points come off

  • Per-dose pricing is gated behind login/signup, not public
  • State availability changes and is only confirmed at signup
  • Compounded medications are not FDA-evaluated

The Desk's briefing — C

Best for: Readers who want cash-pay shoppers wanting low daily-cost compounded GLP-1 with simple online onboarding.

MANÜ Telehealth ranks #388 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect MANÜ Telehealth's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on MANÜ Telehealth's site. Not medical advice; see our disclosure.

← Back to The Desk